APA (7th ed.) Citation

S, D., MS, M., SAM, C., BD, A., MF, K., OF, C., . . . AM, M. (2026). Design and rationale of the Research with EVuzamitide to Evaluate for cardiac AmyLoidosis (REVEAL) positron emission tomography study: A study of 124I-evuzamitide to diagnose cardiac amyloidosis. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology, 61, 102773. https://doi.org/10.1016/j.nuclcard.2026.102773

Chicago Style (17th ed.) Citation

S, Dorbala, et al. "Design and Rationale of the Research with EVuzamitide to Evaluate for Cardiac AmyLoidosis (REVEAL) Positron Emission Tomography Study: A Study of 124I-evuzamitide to Diagnose Cardiac Amyloidosis." Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology 61 (2026): 102773. https://doi.org/10.1016/j.nuclcard.2026.102773.

MLA (9th ed.) Citation

S, Dorbala, et al. "Design and Rationale of the Research with EVuzamitide to Evaluate for Cardiac AmyLoidosis (REVEAL) Positron Emission Tomography Study: A Study of 124I-evuzamitide to Diagnose Cardiac Amyloidosis." Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology, vol. 61, 2026, p. 102773, https://doi.org/10.1016/j.nuclcard.2026.102773.